Koselugo (selumetinib), an oral, selective MEK inhibitor, has been recommended for approval in the European Union (EU) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in ...
Agilus Diagnostics, a leading provider of diagnostic services in India and a subsidiary of Fortis Healthcare Ltd., announces the launch of its ground-breaking AgilusEDGE Comprehensive Genomic Profile ...
Cambridge, Massachusetts Tuesday, September 23, 2025, 18:00 Hrs [IST] ...
Our Bureau, New Delhi Tuesday, September 23, 2025, 12:10 Hrs [IST] ...
NIMHANS launches AYUSH-MANN to create awareness on integrative approaches to treat mental-neuro disorders: Our Bureau, Bengaluru Tuesday, September 23, 2025, 17:15 Hrs [IST] Natio ...
FDI in hospitals and diagnostics hits USD 1.56 billion in FY2025, up 2.3x since FY2022: Rubix Data Sciences: Our Bureau, Mumbai Tuesday, September 23, 2025, 15:50 Hrs [IST] Indias ...
Apollo AyurVAID Hospitals on national Ayurveda Day reinstates focus on safety, quality and measurable clinical outcomes: Our Bureau, Bengaluru Tuesday, September 23, 2025, 15:40 H ...
US FDA extends target action date to review Sanofi’s NDA for tolebrutinib in non-relapsing, secondary progressive multiple sclerosis: Paris Tuesday, September 23, 2025, 16:00 Hr ...
Laxmi Dental partners with lending platform Fibe to facilitate finance for dental procedures: Our Bureau, New Delhi Tuesday, September 23, 2025, 15:30 Hrs [IST] Mumbai-based Laxmi ...
AIOCD expresses gratitude to PM for GST relief on medicines, seeks support on key issues: Peethaambaran Kunnathoor, Chennai ...
FOPE seeks clarification from NPPA on drug pricing following GST 2.0 ...
Dr Reddy’s receives positive CHMP opinion from EMA for AVT03, a proposed biosimilar of Prolia and Xgeva: Our Bureau, Bengaluru Tuesday, September 23, 2025, 13:30 Hrs [IST] Dr Re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback